Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-01-08
2008-01-08
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S005000, C435S007920, C435S008000, C530S300000, C530S350000, C530S387100, C530S387900
Reexamination Certificate
active
09509449
ABSTRACT:
A method for measurement of the hepatitis C virus (HCV) characterized by measuring HCV core antigen and HCV core antibody by their binding with probes in the presence of an anionic surfactant or a non-ionic surfactant, or both.
REFERENCES:
patent: 4148869 (1979-04-01), Deaton
patent: 4639425 (1987-01-01), Baier
patent: 4668639 (1987-05-01), Johannsson
patent: 5032503 (1991-07-01), Khanna et al.
patent: 5330893 (1994-07-01), Gilbert et al.
patent: 5616460 (1997-04-01), Figard
patent: 5627026 (1997-05-01), O'Connor et al.
patent: 5627080 (1997-05-01), Cheng et al.
patent: 5645983 (1997-07-01), Liao et al.
patent: 5811525 (1998-09-01), Rittershaus
patent: 5843450 (1998-12-01), Dawson et al.
patent: 6183949 (2001-02-01), Seidel et al.
patent: 0 173 295 (1986-03-01), None
patent: 0 351 248 (1990-01-01), None
patent: 0 507 615 (1992-04-01), None
patent: 0 967 484 (1999-12-01), None
patent: 2313666 (1981-01-01), None
patent: WO 93/10239 (1993-05-01), None
patent: 2051357 (1997-03-01), None
patent: 60-4938 (1985-02-01), None
patent: 60-24451 (1985-02-01), None
patent: 64-15656 (1989-01-01), None
patent: 06-38765 (1994-02-01), None
patent: 6-300761 (1994-10-01), None
patent: 8-5633 (1996-01-01), None
patent: 8-50133 (1996-02-01), None
patent: 11-108932 (1999-04-01), None
patent: 93/21346 (1993-10-01), None
patent: WO99/06836 (1999-02-01), None
Masalova et al., Detection of hepatitis C virus core protein circulating within different virus particle populations. Journal of Medical Virology 55(1):1-6, May 1998.
Aoyagi et al., Development of a Simple and Highly Sensitive Enzyme Immunoassay for Hepatitis C Virus Core Antigen. Journal of Clinical Microbiology 37(6): 1802-1808, Jun. 1999.
Papatheodoridis et al., Journal of Hepatology, vol. 27, pp. 36-41 (1997).
Ferroni et al. Journal of CLinical Microbiology, vol. 31 No. 6, pp. 1586-1591 (Jun. 1993).
International Search Report dated Oct. 4, 1999, prepared by JPO.
Higa. “Calcium-dependent Bacteriophage DNA Infection,”Letters to the Editor, Journal of Molecular Biology, vol. 53 (1970): pp. 159-162.
Kohler et al. “Continuous cultures of fused cells secreting antibody of predefined specificity,”Nature, vol. 256 (Aug. 7, 1975): pp. 495-497.
Kohler et al. “Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion,”European Journal of Immunology, vol. 6 (1976): pp. 511-519.
Chiba et al. “Serodiagnosis hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus,”Proc. National Academy of Science, vol. 88 (Jun. 1991): pp. 4641-4645.
Takahashi et al. “Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts,”Journal of General Virology, vol. 73 (1992): pp. 667-672.
Sang.Enhanced Sensitivity of a Second Generation ELISA for Antibody to Hepatitis C Virus. 1992, pp. 213-217.
Okamoto et al. “Antibodies Against Synthetic Oligopeptides Deduced from the Putative Core Gene for the Diagnosis of Hepatitis C Virus Infection,”Hepatology, vol. 15, No. 2 (1992): pp. 180-186.
Sallberg et al. “Immunodominant Regions within the Hepatitis C Virus Core and Putative Matrix Proteins,”Journal of Clinical Microbiology, vol. 30, No. 8 (Aug. 1992): pp. 1989-1994.
Machida et al. “Two Distinct Subtypes of hepatitis C Virus Defined by Antibodies Directed to the Putative Core Protein,”Hepatology, vol. 16, No. 4 (1992): pp. 886-891.
Sallberg et al. “Locations of Antibody Binding Sites within Conserved Regions of the Hepatitis C Virus Core Protein,”Journal of Medical Virology, vol. 43 (1994): pp. 62-68.
Kashiwakuma et al. “Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)”,Journal of Immunological Methods, vol. 190 (1996): pp. 79-89.
Hoogenboom. “Designing and optimizing library selection strategies for generating high-affinity antibodies,”Tibtech, vol. 15 (Feb. 1997): pp. 62-70.
Weber et al. “Reduction of Diagnostic Window by New Fourth-Generation Human Immunodeficiency Virus Screening Assays,”Journal of Clinical Microbiology, vol. 36, No. 8 (Aug. 1998): pp. 2235-2239.
Kashiwakuma, et al., Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA), Journal of Immunological Methods 190 (1996) 79-89.
Atherton, et al., “A sensitive Screening Test for the Simultaneous Detectionof Hepatitis B Surface Antigen and Antibody”, Journal of Virological Methods 13 (1986) 245-253.
Van Der Poel, Cees L., “Hepatitis C virus: Into the fourth generation”, VOX SANGUINIS, vol. 67, No. suppl. 3, 1994, pp. 95-98.
Fonseca, et al., “Comparison of reactivity of sera tested in a third generation enzyme immunoassay (EIA) and recombinant immunoblot (RIBA) versus fourth generation EIA for antibody to hepatitis C virus (HCV)”, 96h ASM General Meeting, 1996.
Aoyagi Katsumi
Iida Kumiko
Ohue Chiharu
Yagi Shintaro
Advanced Life Science Institute, Inc.
Lucas Zachariah
Merchant & Gould P.C.
LandOfFree
Method for measurement of hepatitis C virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for measurement of hepatitis C virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for measurement of hepatitis C virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3947383